Alcon & Aravind Deepen Partnership to Close Global Retina Care Gap

COIMBATORE, India – July 24, 2026 – Global eye care leader Alcon and the renowned Aravind Eye Care System today announced a significant expansion of their long-standing partnership with the launch of the Aravind Alcon Global Centre of Excellence (CoE) for Vitreoretinal Surgery Training. This new hub in Coimbatore, India, represents a targeted strike against a growing global health crisis: a severe shortage of specialists trained to treat diseases of the retina.

Building on the foundation of a successful Global Cataract Centre of Excellence established in 2024, this new initiative marks a pivotal move from a high-volume, widely addressed condition to a highly complex, underserved specialty. The centre’s mission is to build a global pipeline of skilled surgeons capable of preventing blindness from retinal diseases, which are becoming increasingly prevalent worldwide.

Addressing a Critical Deficit in Global Vision Care

While cataract surgery has become one of the most successful and scalable medical interventions, access to advanced retina care remains dangerously limited. The disparity is driven by two converging factors: a rising tide of retinal diseases and a stark deficit of specialists to treat them. Conditions like diabetic retinopathy (DR) and age-related macular degeneration (AMD) are now leading causes of irreversible blindness, yet the training required to combat them is long and scarce.

Global workforce projections paint a concerning picture, with some studies estimating a potential 30% inadequacy in the ophthalmology workforce by 2035. The gap is most acute in specialized fields and in developing regions. Data reveals a chasm in access, with low-income countries averaging just 3.7 ophthalmologists per million people, compared to 76.2 per million in high-income nations. Retina specialists, who require years of additional subspecialty training, are even rarer.

This shortage has devastating consequences in regions where retinal diseases are surging. In Latin America, where diabetic retinopathy affects an estimated 22.3% of the diabetic population, cases are projected to increase by 50% in the next 25 years. In Asia, home to a massive and aging population, China alone faces a DR prevalence rate as high as 43% among its diabetic citizens. Meanwhile, studies in sub-Saharan Africa show that nearly half of all eyes diagnosed with retinal conditions suffer from blindness or severe visual impairment. The new CoE is designed to directly confront this challenge by creating a sustainable source of highly trained professionals for these underserved regions.

An Innovative Blueprint for Surgical Education

The Aravind Alcon CoE is more than just a training facility; it's a new model for disseminating complex surgical skills across geographical and economic barriers. The centre pioneers a hybrid educational approach that combines intensive, hands-on training with the scalable reach of virtual learning. At its core is a state-of-the-art wet laboratory, where surgeons can practice complex vitreoretinal procedures in a simulated environment, honing the delicate motor skills required for microsurgery with precision and confidence.

This practical training is augmented by a robust virtual fellowship program. This digital component allows the CoE to transcend its physical walls, delivering world-class curriculum and knowledge to ophthalmologists across Africa, Latin America, and Asia. This model not only makes elite training more accessible and affordable but also allows for continuous learning and mentorship, which are critical for long-term capacity building.

Initially, the centre will train approximately 60 participants on-site annually, but its true impact will be amplified through its virtual programs. By leveraging technology, the partnership aims to create a multiplier effect, rapidly expanding the global pool of surgeons equipped to handle complex retinal cases. This strategy is a direct commercialization insight: it moves beyond simply selling surgical equipment to actively building the human infrastructure necessary to create a sustainable market for advanced eye care.

A Partnership Built on Two Decades of Trust

The launch of the retina CoE is the latest milestone in a partnership spanning more than two decades between Alcon and Aravind Eye Care System. It exemplifies a powerful synergy between a global industry leader and a world-renowned healthcare provider. Alcon brings its 75-year heritage of innovation and a vast portfolio of surgical technologies, while Aravind contributes its unparalleled expertise in delivering high-quality, high-volume, and affordable eye care, along with a proven model for medical education.

"For more than two decades, Alcon and Aravind have partnered to advance surgical education and help strengthen eye care around the world," said Mr. Raj Narayanan, Senior Vice President and President International at Alcon. "The inauguration of this new Global Centre of Excellence in Retina marks an important step in our shared commitment to developing the next generation of eye care professionals through world-class training and capability building."

This collaboration is a masterclass in strategic alignment. For Aravind, it directly serves its mission to eliminate needless blindness. "This comes at a critical time, as retinal disease is an increasingly common cause of vision loss in India and worldwide," stated Dr. Narendran, Chief Medical Officer at Aravind Eye Care Hospital, Coimbatore. "The center provides the next generation of ophthalmologists with a structured, hands-on pathway to master complex procedures with precision and confidence."

For Alcon, the investment is a long-term strategic play that builds both goodwill and a future market. By training surgeons on the latest techniques, which often involve Alcon's advanced vitreoretinal surgical platforms and consumables, the company is cultivating a global ecosystem of skilled users. This initiative demonstrates a sophisticated understanding that true market expansion in specialized healthcare relies on empowering the professionals who deliver the care. Together, the two organizations are not just launching a center; they are scaling a proven solution to improve patient outcomes and expand access to quality treatment for all who need it.